NCT00821392View on ClinicalTrials.gov

Phase III Trial of Febuxostat in Korea Gout Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

181

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions

Gout

Interventions

DRUG

Febuxostat

All Listed Sponsors

lead

SK Chemicals Co., Ltd.

INDUSTRY

NCT00821392 - Phase III Trial of Febuxostat in Korea Gout Patients | Biotech Hunter | Biotech Hunter